| Raymond N. DuBois | |
| Nationality: | American |
| Fields: | Biochemistry and molecular biology |
| Workplaces: | Vanderbilt-Ingram Cancer Center University of Texas MD Anderson Cancer Center Biodesign Institute |
Raymond N. DuBois is an American academic and scientist. He is the incumbent director of the Hollings Cancer Center at the Medical University of South Carolina and executive chairman of the board of the Mark Foundation for Cancer Research.[1] [2] He was the president of the American Association for Cancer Research between 2008 and 2009.[3]
DuBois attended Texas A&M University, where he received a bachelor's degree in biochemistry.[3] [4] Later, he joined a medical school, University of Texas School of Medicine, and completed a medical degree.[3] [4] He also holds a doctorate degree in biochemistry from the University of Texas.[3] [4]
From 1991 to 2007, he was the director of the Vanderbilt-Ingram Cancer Center.[5] [6]
Between 2007 and 2012, DuBois was the provost and executive vice president of the University of Texas MD Anderson Cancer Center.[7] He also held the Ellen Knisely Distinguished Chair in colon cancer research.[8] [3]
In 2012, he joined the Biodesign Institute at Arizona State University as the executive director and served until 2016.[6] [8]
In March 2016, DuBois became the dean of the College of Medicine at the Medical University of South Carolina.[3] [6]
In 2019, he was elected to the National Academy of Medicine.[6]
In 2020, he was appointed as the director of Hollings Cancer Center.[6] [9]
In February 2022, he was appointed as the executive chairman of the board of Mark Foundation for Cancer Research.[2]
DuBois is known for his research on the causes of cancer, its spread, and what prevents it.[6]
DuBois co-invented a method for identifying and targeting cellular genes required for viral development, as well as cellular genes that act as tumour suppressors in mammals.[10]